NYSE:BAX - Baxter International Stock Price, Forecast & News

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, February 18th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.22 per share on Wednesday, April 1st. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date is Thursday, February 27th. View Baxter International's Dividend History.

Baxter International announced that its board has approved a share buyback program on Tuesday, November 13th 2018, which permits the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 6.1% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's management believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) announced its earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a net margin of 13.80% and a return on equity of 22.99%. Baxter International's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.64 EPS. View Baxter International's Earnings History.

17 Wall Street analysts have issued 12 month price objectives for Baxter International's stock. Their forecasts range from $75.00 to $109.00. On average, they expect Baxter International's share price to reach $94.00 in the next year. This suggests a possible upside of 1.0% from the stock's current price. View Analyst Price Targets for Baxter International.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Media stories about BAX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baxter International earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Baxter International.

Baxter International saw a increase in short interest in January. As of January 31st, there was short interest totalling 6,470,000 shares, an increase of 45.1% from the January 15th total of 4,460,000 shares. Based on an average trading volume of 3,060,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 1.3% of the shares of the company are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX), Varian Medical Systems (VAR) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Cisco Systems (CSCO), BlackRock (BLK), Verizon Communications (VZ), Honeywell International (HON), AT&T (T), Pfizer (PFE), Alibaba Group (BABA) and Abbott Laboratories (ABT).

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional investors include Wealth Quarterback LLC (14.07%), State Street Corp (4.68%), Third Point LLC (3.43%), FMR LLC (2.64%), Geode Capital Management LLC (1.41%) and Caisse DE Depot ET Placement DU Quebec (1.34%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bessemer Group Inc., Schroder Investment Management Group, Bank of New York Mellon Corp, AQR Capital Management LLC, Janus Henderson Group PLC, Los Angeles Capital Management & Equity Research Inc. and Argent Capital Management LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Capital International Investors, Bank of Montreal Can, Third Point LLC, Alyeska Investment Group L.P., New York State Common Retirement Fund, PGGM Investments and Stifel Financial Corp. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $93.06.

Baxter International has a market capitalization of $47.51 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]